thefederalregister.org
Federal Register Research Archive
Latest RSS
Changes RSS
Search
Status
Home
/
89 FR 57418
Citation
89 FR 57418
Canonical document for this Federal Register citation.
Takeda Pharmaceuticals U.S.A., Inc.; Withdrawal of Approval of New Drug Application for EXKIVITY (Mobocertinib Succinate) Capsule, Equivalent to 40 Milligrams Base
Monday, July 15, 2024
89 FR 57418